GSA Sets Focus on Optimizing Older Adults’ Pain Care

 

Washington, DC (September 15, 2011) – To highlight Pain Awareness Month in September, The Gerontological Society of America (GSA) — the nation’s largest interdisciplinary organization devoted to the field of aging — is announcing two forthcoming publications focused on pain relief and medication for seniors.

 

Paired with its other recent research findings, GSA aims to provide readers with information on how new advances in pain prevention, treatment, and management may improve care and quality of life for older adults.

Both new publications are part of GSA’s From Publication to Practice series, which aims to promote the translation of research into meaningful health outcomes. They are slated to be released in November 2011.

One of the installments, “An Interdisciplinary Look at Advancing Pain Research, Care, and Education,” will be supported by Purdue Pharma, L.P. It will address shortfalls in pain assessment and treatment for older adults with pain. This resource largely will be based on a recent Institute of Medicine report, “Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.”

The other new issue, “An Interdisciplinary Look at Labeling Changes for Acetaminophen and the Implications for Patient Care,” will be supported by McNeil Consumer Healthcare. In response to several recent significant modifications to the recommended dosage for acetaminophen, it is being produced in order to ensure that clinicians and aging network professionals are aware of these developments and the subsequent implications for patient care.

These publications join a collection of research that GSA has published within the last year on the subject of pain.

For example, the latest edition of the organization’s WHAT’S HOT newsletter demonstrated that improved management of chronic pain can significantly reduce disability in older adults. This issue examines the impact of pain in older adults, strategies for managing pain and preserving function, and methods to improve the assessment and management of pain for residents in long-term care facilities, including those who have dementia. The newsletter points out that pain is a signal that something is wrong, and that reports of pain should not be dismissed simply because the patient is older.

Furthermore, a January 2011 article in the Journals of Gerontology Series A: Biological Sciences and Medical Sciences points out that musculoskeletal pain is associated increased mobility disability in older people. A September 2010 study in the same journal found that seniors with moderate to severe musculoskeletal pain had more than twice the risk for impaired balance compared with those without pain.

 

 

The Gerontological Society of America (GSA) is the nation’s oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging. The principal mission of the Society — and its 5,400+ members — is to advance the study of aging and disseminate information among scientists, decision makers, and the general public. GSA’s structure also includes a policy institute, the National Academy on an Aging Society, and an educational branch, the Association for Gerontology in Higher Education.

 


 

The Gerontological Society of America (GSA), 15.09.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…